{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:53Z","timestamp":1792512713953,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230005"],"award-info":[{"award-number":["82230005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200133"],"award-info":[{"award-number":["82200133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74774-7","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:06:32Z","timestamp":1782313592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neutrophil-derived S100A8\/A9 impairs megakaryocyte maturation in immune thrombocytopenia"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiaqian","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2001-2354","authenticated-orcid":false,"given":"Ziyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-3863","authenticated-orcid":false,"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7560-7195","authenticated-orcid":false,"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"74774_CR1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/bjh.17324","volume":"193","author":"N Cooper","year":"2021","unstructured":"Cooper, N. et al. How I treat immune thrombocytopenia - a global view. Br. J. Haematol. 193, 1076\u20131086 (2021).","journal-title":"Br. J. Haematol."},{"key":"74774_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1056\/NEJMcp1810479","volume":"381","author":"N Cooper","year":"2019","unstructured":"Cooper, N. & Ghanima, W. Immune Thrombocytopenia. N. Engl. J. Med. 381, 945\u2013955 (2019).","journal-title":"N. Engl. J. Med."},{"key":"74774_CR3","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero, F. et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113, 2386\u20132393 (2009).","journal-title":"Blood"},{"key":"74774_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-023-01401-z","volume":"16","author":"XG Liu","year":"2023","unstructured":"Liu, X. G., Hou, Y. & Hou, M. How we treat primary immune thrombocytopenia in adults. J. Hematol. Oncol. 16, 4 (2023).","journal-title":"J. Hematol. Oncol."},{"key":"74774_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/11208260-000000000-00000","volume":"72","author":"GM Keating","year":"2012","unstructured":"Keating, G. M. Romiplostim: a review of its use in immune thrombocytopenia. Drugs 72, 415\u2013435 (2012).","journal-title":"Drugs"},{"key":"74774_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s40265-019-01159-0","volume":"79","author":"B Fattizzo","year":"2019","unstructured":"Fattizzo, B., Levati, G., Cassin, R. & Barcellini, W. Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation. Drugs 79, 1305\u20131319 (2019).","journal-title":"Drugs"},{"key":"74774_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1182\/blood.2019003599","volume":"135","author":"O Miltiadous","year":"2020","unstructured":"Miltiadous, O., Hou, M. & Bussel, J. B. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood 135, 472\u2013490 (2020).","journal-title":"Blood"},{"key":"74774_CR8","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/ajh.27433","volume":"99","author":"P Zhao","year":"2024","unstructured":"Zhao, P. et al. Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot study. Am. J. Hematol. 99, 1951\u20131958 (2024).","journal-title":"Am. J. Hematol."},{"key":"74774_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/ajh.27131","volume":"99","author":"N Cooper","year":"2024","unstructured":"Cooper, N. et al. Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial. Am. J. Hematol. 99, 57\u201367 (2024).","journal-title":"Am. J. Hematol."},{"key":"74774_CR10","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood-2003-07-2268","volume":"103","author":"FP Panitsas","year":"2004","unstructured":"Panitsas, F. P. et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 103, 2645\u20132647 (2004).","journal-title":"Blood"},{"key":"74774_CR11","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","volume":"113","author":"DB Cines","year":"2009","unstructured":"Cines, D. B., Bussel, J. B., Liebman, H. A. & Luning Prak, E. T. The ITP syndrome: pathogenic and clinical diversity. Blood 113, 6511\u20136521 (2009).","journal-title":"Blood"},{"key":"74774_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54309-8","volume":"15","author":"O Oshinowo","year":"2024","unstructured":"Oshinowo, O. et al. Autoantibodies immuno-mechanically modulate platelet contractile force and bleeding risk. Nat. Commun. 15, 10201 (2024).","journal-title":"Nat. Commun."},{"key":"74774_CR13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1182\/blood.2020009497","volume":"137","author":"PAA Norris","year":"2021","unstructured":"Norris, P. A. A. et al. Anti-inflammatory activity of CD44 antibodies in murine immune thrombocytopenia is mediated by Fcgamma receptor inhibition. Blood 137, 2114\u20132124 (2021).","journal-title":"Blood"},{"key":"74774_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick, A. R., Weber, D. J. & Zimmer, D. B. S100 proteins in cancer. Nat. Rev. Cancer 15, 96\u2013109 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"74774_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","volume":"24","author":"J Roth","year":"2003","unstructured":"Roth, J., Vogl, T., Sorg, C. & Sunderkotter, C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155\u2013158 (2003).","journal-title":"Trends Immunol."},{"key":"74774_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41392-022-01167-9","volume":"7","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia. Signal Transduct. Target Ther. 7, 347 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"74774_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155376","volume":"144","author":"L Du","year":"2023","unstructured":"Du, L. et al. Inhibition of S100A8\/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy. Metabolism 144, 155376 (2023).","journal-title":"Metabolism"},{"key":"74774_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jth.15176","volume":"19","author":"J Sui","year":"2021","unstructured":"Sui, J. et al. Plasma levels of S100A8\/A9, histone\/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura. J. Thromb. Haemost. 19, 370\u2013379 (2021).","journal-title":"J. Thromb. Haemost."},{"key":"74774_CR19","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/bloodadvances.2022008958","volume":"7","author":"YH Wang","year":"2023","unstructured":"Wang, Y. H. et al. High BM plasma S100A8\/A9 is associated with a perturbed microenvironmentand poor prognosis in myelodysplastic syndromes. Blood Adv. 7, 2528\u20132533 (2023).","journal-title":"Blood Adv."},{"key":"74774_CR20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1158\/2767-9764.CRC-22-0368","volume":"3","author":"C Lin","year":"2023","unstructured":"Lin, C. et al. S100A8\/S100A9 promote progression of multiple myeloma via expansion of megakaryocytes. Cancer Res. Commun. 3, 420\u2013430 (2023).","journal-title":"Cancer Res. Commun."},{"key":"74774_CR21","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.immuni.2022.10.001","volume":"55","author":"T Petzold","year":"2022","unstructured":"Petzold, T. et al. Neutrophil \u201cplucking\u201d on megakaryocytes drives platelet production and boosts cardiovascular disease. Immunity 55, 2285\u20132299 e2287 (2022).","journal-title":"Immunity"},{"key":"74774_CR22","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1182\/bloodadvances.2021005097","volume":"6","author":"FY Huang","year":"2022","unstructured":"Huang, F. Y. et al. Neutrophil transit time and localization within the megakaryocyte define morphologically distinct forms of emperipolesis. Blood Adv. 6, 2081\u20132091 (2022).","journal-title":"Blood Adv."},{"key":"74774_CR23","doi-asserted-by":"publisher","unstructured":"Cunin, P. et al. Megakaryocyte emperipolesis mediates membrane transfer from intracytoplasmic neutrophils to platelets. Elife 8, https:\/\/doi.org\/10.7554\/eLife.44031 (2019).","DOI":"10.7554\/eLife.44031"},{"key":"74774_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1083\/jcb.201410052","volume":"209","author":"S Nishimura","year":"2015","unstructured":"Nishimura, S. et al. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J. Cell Biol. 209, 453\u2013466 (2015).","journal-title":"J. Cell Biol."},{"key":"74774_CR25","doi-asserted-by":"publisher","unstructured":"Okoye-Okafor, U. C. et al. Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine. J. Exp. Med. 219, https:\/\/doi.org\/10.1084\/jem.20212228 (2022).","DOI":"10.1084\/jem.20212228"},{"key":"74774_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103605","volume":"23","author":"P David","year":"2024","unstructured":"David, P., Santos, G. M., Patt, Y. S., Orsi, F. A. & Shoenfeld, Y. Immune thrombocytopenia (ITP) - could it be part of autoimmune\/inflammatory syndrome induced by adjuvants (ASIA)? Autoimmun. Rev. 23, 103605 (2024).","journal-title":"Autoimmun. Rev."},{"key":"74774_CR27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1160\/TH15-12-0976","volume":"115","author":"M Jernas","year":"2016","unstructured":"Jernas, M. et al. Normalised immune expression in remission of paediatric ITP. Thromb. Haemost. 115, 1229\u20131230 (2016).","journal-title":"Thromb. Haemost."},{"key":"74774_CR28","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1182\/blood-2013-05-502807","volume":"122","author":"M Jernas","year":"2013","unstructured":"Jernas, M. et al. Differences in gene expression and cytokine levels between newly diagnosed and chronic pediatric ITP. Blood 122, 1789\u20131792 (2013).","journal-title":"Blood"},{"key":"74774_CR29","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1182\/blood-2010-09-304931","volume":"117","author":"B Zhang","year":"2011","unstructured":"Zhang, B. et al. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood 117, 4569\u20134579 (2011).","journal-title":"Blood"},{"key":"74774_CR30","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1182\/blood-2010-02-267435","volume":"116","author":"L Yang","year":"2010","unstructured":"Yang, L. et al. Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia. Blood 116, 4307\u20134316 (2010).","journal-title":"Blood"},{"key":"74774_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.stem.2020.11.006","volume":"28","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Decoding Human Megakaryocyte Development. Cell Stem Cell 28, 535\u2013549 e538 (2021).","journal-title":"Cell Stem Cell"},{"key":"74774_CR32","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1182\/blood.2020009302","volume":"139","author":"J Tilburg","year":"2022","unstructured":"Tilburg, J., Becker, I. C. & Italiano, J. E. Don\u2019t you forget about me(gakaryocytes). Blood 139, 3245\u20133254 (2022).","journal-title":"Blood"},{"key":"74774_CR33","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1182\/blood.V93.9.2867.409k24_2867_2875","volume":"93","author":"P Vyas","year":"1999","unstructured":"Vyas, P., Ault, K., Jackson, C. W., Orkin, S. H. & Shivdasani, R. A. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 93, 2867\u20132875 (1999).","journal-title":"Blood"},{"key":"74774_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537\u2013549 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"74774_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrm906","volume":"3","author":"KA Gallo","year":"2002","unstructured":"Gallo, K. A. & Johnson, G. L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3, 663\u2013672 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"74774_CR36","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1182\/blood-2007-06-098558","volume":"111","author":"K Freson","year":"2008","unstructured":"Freson, K. et al. PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications. Blood 111, 1885\u20131893 (2008).","journal-title":"Blood"},{"key":"74774_CR37","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2024","unstructured":"Rauluseviciute, I. et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res 52, D174\u2013D182 (2024).","journal-title":"Nucleic Acids Res"},{"key":"74774_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18515-4","volume":"11","author":"KK Dey","year":"2020","unstructured":"Dey, K. K. et al. Evaluating the informativeness of deep learning annotations for human complex diseases. Nat. Commun. 11, 4703 (2020).","journal-title":"Nat. Commun."},{"key":"74774_CR39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1182\/blood.2020008477","volume":"138","author":"P Han","year":"2021","unstructured":"Han, P. et al. Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia. Blood 138, 674\u2013688 (2021).","journal-title":"Blood"},{"key":"74774_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/17512433.2021.1903315","volume":"14","author":"R Sandal","year":"2021","unstructured":"Sandal, R., Mishra, K., Jandial, A., Sahu, K. K. & Siddiqui, A. D. Update on diagnosis and treatment of immune thrombocytopenia. Expert Rev. Clin. Pharm. 14, 553\u2013568 (2021).","journal-title":"Expert Rev. Clin. Pharm."},{"key":"74774_CR41","unstructured":"Justiz Vaillant, A. A. & Gupta, N. in StatPearls (2025)."},{"key":"74774_CR42","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1161\/CIRCULATIONAHA.119.043833","volume":"141","author":"G Sreejit","year":"2020","unstructured":"Sreejit, G. et al. Neutrophil-Derived S100A8\/A9 Amplify Granulopoiesis After Myocardial Infarction. Circulation 141, 1080\u20131094 (2020).","journal-title":"Circulation"},{"key":"74774_CR43","doi-asserted-by":"crossref","unstructured":"A feedback loop between platelets and NETs amplifies inflammation in severe sepsis. Nat. Cardiovasc. Res. 1, 698\u2013699 (2022).","DOI":"10.1038\/s44161-022-00110-z"},{"key":"74774_CR44","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1182\/blood.2021014966","volume":"140","author":"M Colicchia","year":"2022","unstructured":"Colicchia, M. et al. S100A8\/A9 drives the formation of procoagulant platelets through GPIbalpha. Blood 140, 2626\u20132643 (2022).","journal-title":"Blood"},{"key":"74774_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","volume":"69","author":"O Krenkel","year":"2020","unstructured":"Krenkel, O. et al. Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis. Gut 69, 551\u2013563 (2020).","journal-title":"Gut"},{"key":"74774_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.226","volume":"3","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Single-cell landscape revealed immune characteristics associated with disease phases in brucellosis patients. Imeta 3, e226 (2024).","journal-title":"Imeta"},{"key":"74774_CR47","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","volume":"140","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. S100a8\/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic\/reperfusion injury. Circulation 140, 751\u2013764 (2019).","journal-title":"Circulation"},{"key":"74774_CR48","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1093\/eurheartj\/ehz524","volume":"40","author":"NG Frangogiannis","year":"2019","unstructured":"Frangogiannis, N. G. S100A8\/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges. Eur. Heart J. 40, 2724\u20132726 (2019).","journal-title":"Eur. Heart J."},{"key":"74774_CR49","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s44161-022-00108-7","volume":"1","author":"M Su","year":"2022","unstructured":"Su, M. et al. Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis. Nat. Cardiovasc. Res. 1, 732\u2013747 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"74774_CR50","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41423-020-0492-x","volume":"17","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. Elevated serum levels of S100A8\/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol. Immunol. 17, 992\u2013994 (2020).","journal-title":"Cell Mol. Immunol."},{"key":"74774_CR51","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1053\/j.gastro.2020.08.019","volume":"159","author":"M Willers","year":"2020","unstructured":"Willers, M. et al. S100A8 and S100A9 are important for postnatal development of gut microbiota and immune system in mice and infants. Gastroenterology 159, 2130\u20132145.e2135 (2020).","journal-title":"Gastroenterology"},{"key":"74774_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38086-1","volume":"9","author":"M Grodzielski","year":"2019","unstructured":"Grodzielski, M. et al. Multiple concomitant mechanisms contribute to low platelet count in patients with immune thrombocytopenia. Sci. Rep. 9, 2208 (2019).","journal-title":"Sci. Rep."},{"key":"74774_CR53","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1371\/journal.pbio.1000097","volume":"7","author":"P Bjork","year":"2009","unstructured":"Bjork, P. et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 7, e97 (2009).","journal-title":"PLoS Biol."},{"key":"74774_CR54","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-12-2730","volume":"73","author":"JT Isaacs","year":"2013","unstructured":"Isaacs, J. T. et al. Tasquinimod is an allosteric modulator of HDAC4 survival signaling within the compromised cancer microenvironment. Cancer Res. 73, 1386\u20131399 (2013).","journal-title":"Cancer Res."},{"key":"74774_CR55","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41392-024-02033-6","volume":"9","author":"S Wu","year":"2024","unstructured":"Wu, S. et al. BRAF inhibitors enhance erythropoiesis and treat anemia through paradoxical activation of MAPK signaling. Signal Transduct. Target Ther. 9, 338 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"74774_CR56","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s10517-020-04880-z","volume":"169","author":"GN Zyuz\u2019kov","year":"2020","unstructured":"Zyuz\u2019kov, G. N. et al. Hemostimulating effects of c-Jun N-Terminal Kinase (JNK) inhibitor during cytostatic myelosuppression and mechanisms of their development. Bull. Exp. Biol. Med. 169, 332\u2013337 (2020).","journal-title":"Bull. Exp. Biol. Med."},{"key":"74774_CR57","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41421-018-0072-8","volume":"5","author":"X Xiao","year":"2019","unstructured":"Xiao, X. et al. Targeting JNK pathway promotes human hematopoietic stem cell expansion. Cell Discov. 5, 2 (2019).","journal-title":"Cell Discov."},{"key":"74774_CR58","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","volume":"129","author":"MP Lambert","year":"2017","unstructured":"Lambert, M. P. & Gernsheimer, T. B. Clinical updates in adult immune thrombocytopenia. Blood 129, 2829\u20132835 (2017).","journal-title":"Blood"},{"key":"74774_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00967-22","volume":"96","author":"RB Undi","year":"2022","unstructured":"Undi, R. B. et al. Targeting Doublecortin-like Kinase 1 (DCLK1)-regulated SARS-CoV-2 pathogenesis in COVID-19. J. Virol. 96, e0096722 (2022).","journal-title":"J. Virol."},{"key":"74774_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/bjh.19076","volume":"203","author":"G Moulis","year":"2023","unstructured":"Moulis, G. & Garabet, L. Markers of refractory primary immune thrombocytopenia. Br. J. Haematol. 203, 112\u2013118 (2023).","journal-title":"Br. J. Haematol."},{"key":"74774_CR61","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/bjh.17506","volume":"194","author":"ME Mingot-Castellano","year":"2021","unstructured":"Mingot-Castellano, M. E. et al. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain. Br. J. Haematol. 194, 537\u2013541 (2021).","journal-title":"Br. J. Haematol."},{"key":"74774_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bjh.19082","volume":"203","author":"TJ Gonzalez-Lopez","year":"2023","unstructured":"Gonzalez-Lopez, T. J. & Schifferli, A. Early immunomodulation in immune thrombocytopenia-A report of the ICIS meeting in Lenzerheide, Switzerland 2022. Br. J. Haematol. 203, 101\u2013111 (2023).","journal-title":"Br. J. Haematol."},{"key":"74774_CR63","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1182\/blood.V99.4.1482","volume":"99","author":"G Emilia","year":"2002","unstructured":"Emilia, G. et al. Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. Blood 99, 1482\u20131485 (2002).","journal-title":"Blood"},{"key":"74774_CR64","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan, D. et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 3, 3780\u20133817 (2019).","journal-title":"Blood Adv."},{"key":"74774_CR65","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41592-023-01791-5","volume":"20","author":"HM Bennett","year":"2023","unstructured":"Bennett, H. M., Stephenson, W., Rose, C. M. & Darmanis, S. Single-cell proteomics enabled by next-generation sequencing or mass spectrometry. Nat. Methods 20, 363\u2013374 (2023).","journal-title":"Nat. Methods"},{"key":"74774_CR66","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s41587-023-01881-x","volume":"42","author":"FV De Rop","year":"2024","unstructured":"De Rop, F. V. et al. Systematic benchmarking of single-cell ATAC-sequencing protocols. Nat. Biotechnol. 42, 916\u2013926 (2024).","journal-title":"Nat. Biotechnol."},{"key":"74774_CR67","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2020.08.007","volume":"182","author":"RAT Mars","year":"2020","unstructured":"Mars, R. A. T. et al. Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable Bowel Syndrome. Cell 182, 1460\u20131473.e1417 (2020).","journal-title":"Cell"},{"key":"74774_CR68","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1182\/blood.V79.8.1907.1907","volume":"79","author":"E Lagasse","year":"1992","unstructured":"Lagasse, E. & Weissman, I. L. Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. Blood 79, 1907\u20131915 (1992).","journal-title":"Blood"},{"key":"74774_CR69","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41584-018-0058-9","volume":"14","author":"J Austermann","year":"2018","unstructured":"Austermann, J., Spiekermann, C. & Roth, J. S100 proteins in rheumatic diseases. Nat. Rev. Rheumatol. 14, 528\u2013541 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"74774_CR70","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74774-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74774-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:03:21Z","timestamp":1786100601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74774-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74774"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74774-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7941"}}